These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Chemotherapy of metastatic cancer of the bladder. Apropos of 50 patients treated with M-VAC]. Beuzeboc P, Dhote R, Thiounn N, Flam T, Zerbib M, Debré B, Pouillart P. Cancer Radiother; 1998 Apr; 2 Suppl 1():92s-96s. PubMed ID: 9749087 [Abstract] [Full Text] [Related]
10. [Place of chemotherapy in the treatment of invasive bladder tumors]. Pariente JL, Theodore C, Davin JL, Rischmann P, Chopin D. Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944 [Abstract] [Full Text] [Related]
11. [Neoadjuvant chemotherapy for invasive bladder cancer]. Kageyama Y, Kihara K. Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476 [Abstract] [Full Text] [Related]
12. Southwest Oncology Group Study 8710: trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080). Crawford ED, Natale RB, Burton H. Prog Clin Biol Res; 1990 Nov; 353():111-3. PubMed ID: 2217407 [No Abstract] [Full Text] [Related]
13. Overview of systemic treatment of bladder cancer and results with M-VAC therapy. Yagoda A. Prog Clin Biol Res; 1990 Nov; 350():87-99. PubMed ID: 2201047 [Abstract] [Full Text] [Related]
18. [MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC]. Seguchi T, Nakano E, Miki T, Kondoh M, Nishimura K, Nakamura N, Okuyama A. Gan To Kagaku Ryoho; 1994 Jan; 21(1):59-65. PubMed ID: 8291917 [Abstract] [Full Text] [Related]